Alzamend Neuro (ALZN)
(Delayed Data from NSDQ)
$2.27 USD
-0.11 (-4.62%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.26 -0.01 (-0.44%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Alzamend Neuro, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ALZN 2.27 -0.11(-4.62%)
Will ALZN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ALZN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALZN
Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?
ALZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ALZN
Alzamend Neuro (ALZN) to Present at Military Health Symposium
Alzamend Neuro to Present at the 2025 Military Health System Research Symposium | ALZN Stock News
Alzamend Neuro to present at Military Health System Research Symposium
Alzamend Neuro (ALZN) Strengthens Financial Position with Strategic Achievements | ALZN Stock News
Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs | ...